# FDA Inspection 1238909 - Merakris Therapeutics, LLC - May 15, 2024

Source: https://www.keypedia.com/records/fda_inspections/merakris-therapeutics-llc/a9093b7a-997a-4360-8376-3d215ff979f7
Source feed: FDA_Inspections

> FDA Inspection 1238909 for Merakris Therapeutics, LLC on May 15, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1238909
- Company Name: Merakris Therapeutics, LLC
- Inspection Date: 2024-05-15
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1177756 - 2022-06-30](https://www.keypedia.com/records/fda_inspections/merakris-therapeutics-llc/f3b9ab0d-4f34-445d-863c-7f93f2a946fe)
- [FDA Inspection 1177756 - 2022-06-30](https://www.keypedia.com/records/fda_inspections/merakris-therapeutics-llc/30e231aa-b63e-4423-98b5-05610c726f6e)

Company: https://www.keypedia.com/companies/merakris-therapeutics-llc/b3540a6f-f3bd-466a-9c59-716751c73d07

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d